Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement
- Conditions
- InfectionsPacemaker Complication
- Interventions
- Procedure: Partial capsule decortication
- Registration Number
- NCT05390216
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Brief Summary
Increasing number of cardiac implantable electronic devices (CIEDs) have been implanted in the worldwide every year, which is accompanied by the growing number of CIED-related infection, especially in patients with CIED replacement. This multicenter, prospective, single-blinded, randomized controlled trial is to confirm the impact of partial capsule decortication on device-related infection in patients receiving CIED replacement.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 1016
-
Patient is at least 18 years of age
-
Patient is planned to undergo at least one of the following procedures:
a) Patient has existing CIED (pacemaker, or CRT-P, or ICD, or CRT-D) and is undergoing pulse generator replacement or upgrade with a new generator. b) Patients planned to have leads added, or extracted and added for upgrades.
-
Patient is willing to sign and date informed consent
- History of CIED-related infection
- Open the pocket for any reason within the last one year
- Any evidence indicating active infection
- Requirement of long term vascular access for any reason
- Expected survival time is less than one year
- Patients who were pregnant or breastfeeding
- Participation in another study that may confound the results of this study
- Patient is unable to comply with scheduled follow up
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Partial capsule decortication Partial capsule decortication -
- Primary Outcome Measures
Name Time Method Rate of major CIED-related infection Within the first year after the operation Infections that resulted in CIED system removal, an invasive CIED procedure (e.g., pocket revision without removal), treatment with long-term antibiotic therapy (if the patient was not a candidate for system removal) with infection recurrence after discontinuation of antibiotic therapy, or death.
- Secondary Outcome Measures
Name Time Method Rate of device dysfunction Within the first year after the operation All the dysfunction of the generators and leads (including abnormal changes of pacing threshold, sensing, impedance, etc.).
All-cause mortality Within the first year after the operation Death regardless of the causes.
Rate of all CIED-related infection Within the first year after the operation All infections that related to CIED operation.
Rate of minor CIED-related infection Within the first year after the operation Infections that do not meet the definition criteria of major CIED infection.
Rate of pocket hematoma Within the first year after the operation Palpable swelling with fluctuance that extended beyond the device margin but without evidence of infection.
Trial Locations
- Locations (1)
180 Fenglin Road
🇨🇳Shanghai, Shanghai, China